Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 53.07B | 53.10B | 54.23B | 63.05B | 79.02B | 77.87B |
Gross Profit | 15.79B | 17.34B | 21.71B | 26.87B | 43.81B | 43.61B |
EBITDA | 1.11B | 1.20B | 11.24B | 21.30B | 33.87B | 36.12B |
Net Income | -20.50B | -18.76B | 1.69B | 8.01B | 19.87B | 20.90B |
Balance Sheet | ||||||
Total Assets | 192.52B | 196.49B | 191.57B | 182.10B | 168.41B | 153.09B |
Cash, Cash Equivalents and Short-Term Investments | 21.21B | 22.06B | 25.03B | 28.34B | 28.41B | 23.89B |
Total Debt | 50.76B | 50.01B | 49.28B | 42.05B | 38.10B | 36.40B |
Total Liabilities | 86.77B | 91.45B | 81.61B | 78.82B | 73.02B | 72.05B |
Stockholders Equity | 97.88B | 99.27B | 105.59B | 101.42B | 95.39B | 81.04B |
Cash Flow | ||||||
Free Cash Flow | -10.94B | -15.66B | -14.28B | -9.62B | 9.13B | 20.93B |
Operating Cash Flow | 10.08B | 8.29B | 11.47B | 15.43B | 29.46B | 35.38B |
Investing Cash Flow | -8.53B | -18.26B | -24.04B | -10.23B | -24.28B | -20.80B |
Financing Cash Flow | -3.14B | 11.14B | 8.51B | 1.11B | -6.21B | -12.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
86 Outperform | $4.17T | 48.56 | 109.42% | 0.02% | 71.55% | 64.54% | |
81 Outperform | $294.28B | 28.85 | 56.14% | 0.87% | 27.09% | 40.94% | |
78 Outperform | $1.44T | 78.24 | 27.08% | 0.69% | 28.01% | 235.66% | |
77 Outperform | $262.56B | 93.13 | 4.70% | ― | 27.17% | 108.67% | |
77 Outperform | $982.89B | 26.34 | 33.29% | 1.15% | 38.65% | 57.18% | |
61 Neutral | $35.52B | 8.84 | -11.06% | 1.87% | 8.55% | -8.14% | |
58 Neutral | $107.72B | ― | -19.24% | 0.51% | -3.72% | -2120.70% |
On September 5, 2025, Intel Corporation filed a prospectus supplement with the SEC to register the potential resale of a warrant and shares of common stock by the U.S. Department of Commerce. This filing, required by a prior agreement, does not involve a sale by Intel, and the company will not receive proceeds from any resale by the Department of Commerce.
On August 27, 2025, Intel Corporation and the U.S. Department of Commerce amended their Direct Funding Agreement, removing several obligations for Intel, including project milestone requirements and workforce policy mandates, while maintaining certain restrictions under the CHIPS Act. This amendment facilitated the closing of the Purchase Agreement, resulting in Intel receiving $5.695 billion in accelerated disbursements and issuing shares and warrants to the DOC, impacting Intel’s financial operations and strategic positioning in the semiconductor industry.
On August 22, 2025, Intel Corporation entered into a significant agreement with the United States Department of Commerce, involving an $8.9 billion investment by the U.S. government in Intel’s common stock. This transaction, part of the CHIPS Act and Secure Enclave program, aims to bolster Intel’s role in expanding the domestic semiconductor industry. The agreement includes the issuance of shares and warrants to the U.S. government, with the government holding a 9.9% stake in Intel. This investment reflects confidence in Intel’s ability to advance national priorities and strengthen the U.S. semiconductor supply chain. However, the transaction also presents risks, such as potential dilution of existing shareholders and uncertainties regarding funding and regulatory changes. The U.S. government’s involvement may impact Intel’s operations and strategic decisions, particularly in international markets.
On August 18, 2025, Intel Corporation announced a $2 billion investment agreement with SoftBank Group Corp., under which SoftBank will purchase 86,956,522 shares of Intel’s common stock at $23 per share. This strategic investment aims to bolster semiconductor innovation in the U.S. and supports SoftBank’s vision of accelerating the AI revolution by enhancing access to advanced technologies. The transaction is subject to customary closing conditions, including regulatory approvals.
On April 14, 2025, Intel Corporation entered into a transaction agreement to sell a majority interest in its Altera business to SLP VII Gryphon Aggregator, L.P. An amendment to this agreement was made on August 11, 2025, adjusting the purchase price calculations and extending the closing date to September 13, 2025. The transaction is expected to impact Intel’s operations, with potential risks including regulatory approval delays, changes in business relationships, and competition in the semiconductor industry.
In the second quarter of 2025, Intel announced a significant restructuring initiative aimed at simplifying operations, enhancing transparency, and reallocating resources to core business areas. This plan, approved by the Audit Committee on July 10, 2025, includes a 15% reduction in the workforce and is expected to incur $1.9 billion in restructuring charges, primarily recognized in the second quarter. The initiative aims to improve efficiency and financial discipline, with a focus on strengthening Intel’s core product portfolio and AI roadmap. Despite these efforts, Intel reported a flat revenue of $12.9 billion for Q2 2025 and a GAAP EPS loss of $(0.67), impacted by restructuring charges. The company is targeting $17 billion in non-GAAP operating expenses for 2025 and $18 billion in gross capital expenditures.